Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia is a complex condition with no definitive treatment.

Recombinant Filaggrin-2 microneedles effectively promote hair growth and repair in hair loss.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Hepatitis C treatment may cause frontal fibrosing alopecia.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.

Finasteride can help regrow hair in male pattern baldness.

A hair growth ointment improved hair length in a family with a genetic hair growth condition.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Retinoic acid is not linked to hair loss from fluconazole use.

Finasteride effectively treats male pattern baldness.

Finasteride and luteolin may help promote hair growth.

Applying valproic acid on the scalp increased hair growth in men with hair loss.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

FFA's causes may include environmental triggers and genetic factors.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Medication 1 improved hair quality and growth more effectively than medication 2 and the placebo.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

A new topical finasteride gel using nanoparticles shows promise for safe and effective hair regrowth.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.